Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Grp LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 32.50p 30.00p 35.00p - - - 0.00 16:29:50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -0.3 -0.1 - 11.85

Salvarx Grp Share Discussion Threads

Showing 51 to 71 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
17/11/2016
13:59
with your reputation Mr Holden it probably isn't a good idea to cast stones.
loveandmoney1
17/11/2016
13:57
He doesn't present any substantive analysis to back up his views, usual shooting from the lip.
the stigologist
17/11/2016
13:23
Sorry do tell, I thought he was a fan.
korvet
17/11/2016
13:23
Did tell Stig
korvet
07/11/2016
10:52
That would be pretty satisfactory.Good luck K.Fig.
fig1
14/10/2016
08:31
Yes, I was kind of thinking a pound within 18mths and all going well 2£ 3 to 5 years as they have at least 2 to 3 projects on the go and an attitude to squire more.
korvet
13/10/2016
13:30
3-5 year project for me here K.Regards,Fig.
fig1
13/10/2016
12:12
Wouldn't we all, I've been in when they crashed from a £ but never when they have skyrocketed to a £ and beyond. Still we all live in hope lol 😁
korvet
13/10/2016
11:04
After another top-up,would love to see £1 for this.Fig.
fig1
11/10/2016
10:43
That's what we like, courage of conviction. Unfortunately I can't get anymore till April k
korvet
10/10/2016
20:34
Still accumulating K.Fig.
fig1
10/10/2016
16:47
Yep that'll do it. Well done sir.
korvet
10/10/2016
12:13
Thought we might get a lift from my 33k buy.Fig.
fig1
10/10/2016
09:02
Thought we might get a lift from that article.
korvet
09/10/2016
10:47
Immunotherapy cancer drug hailed as 'game changer' - http://www.bbc.co.uk/news/health-37588541
fig1
04/10/2016
15:29
First slug of SALV taken today.I'll be accumulating as more funds become available.In for the long haul.It's the way of the future!Fig.
fig1
14/9/2016
07:20
Corporate Video SalvaRx (LON: SALV), the drug discovery company focused on cancer immunotherapies, is pleased to announce a new corporate video which can be viewed at hTtps://www.youtube.com/watch?v=F3ywIVrJ-S4&app=desktop.
the stigologist
17/8/2016
21:29
Back to float price so now going in the right direction. Thanks wiseacre...there doesn't seem to be many interested here at the moment but very soon!! IMO
moormoney
15/8/2016
10:23
Buyers back today.
moormoney
09/8/2016
12:41
I'm in for a few of these today! Hoping the company succeeds very much.
moormoney
30/7/2016
20:56
A few months old, but still of interest: "Jim Mellon-backed biotech to join Aim SalvaRX working on treatments using T-cells to attack tumours MARCH 21, 2016 by: Andrew Ward, Pharmaceuticals Correspondent An experimental cancer drug discovered at Oxford university is the focus of a new UK biotech company to be listed in London this week led by two veterans of Bristol-Myers Squibb, the large US pharmaceuticals group." https://next.ft.com/content/a5a400b4-ed1d-11e5-888e-2eadd5fbc4a4 P.S. Please note the following thread which may be of interest: "THE REVERSE TAKEOVERS & SHELLS THREAD (RTO)" http://uk.advfn.com/cmn/fbb/thread.php3?id=31587598
hedgehog 100
Chat Pages: 3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20161209 05:53:55